Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-07

Clinical Trial Update: Testosterone Replacement Therapy in Chronic Spinal Cord Injury [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2 and Phase 3 trial results on testosterone replacement therapy for individuals with chronic spinal cord injury and hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Spinal Cord Injury, Hypogonadism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-04-07